- Trials with a EudraCT protocol (24)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
24 result(s) found for: alfasigma.
Displaying page 1 of 2.
EudraCT Number: 2020-000110-15 | Sponsor Protocol Number: SX-CVD3001/2020 | Start Date*: 2021-08-11 | |||||||||||
Sponsor Name:Alfasigma S.p.A. | |||||||||||||
Full Title: Multicentre, multinational, randomised, double blind, placebo-controlled study on Sulodexide for the management of leg symptoms in patients with chronic venous disease - VEINS (VEnous INvestigation... | |||||||||||||
Medical condition: Chronic Venous Disease | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: CZ (Completed) SK (Completed) PL (Completed) IT (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2017-003722-33 | Sponsor Protocol Number: REROS/001/17 | Start Date*: 2018-03-02 | |||||||||||
Sponsor Name:ALFASIGMA S.P.A. | |||||||||||||
Full Title: Safety and Efficacy of Rifaximin Delayed Release 400 mg Tablets in Patients with Moderate-to-Severe Papulopustular Rosacea and Positive Lactulose Breath Test. A Multicenter Double-Blind, Placebo-Co... | |||||||||||||
Medical condition: Moderate-to-Severe Papulopustular Rosacea and Positive Lactulose Breath Test | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Ongoing) DE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2020-002565-34 | Sponsor Protocol Number: ERACLES01/2020 | Start Date*: 2021-03-10 | |||||||||||
Sponsor Name:SOCIETA' ITALIANA DI ENDOSCOPIA DIGESTIVA - SIED | |||||||||||||
Full Title: Evaluation of 2 different Regimens of colon preparation for an Advanced CLEaning using a 2lt peg-cs with simethicone: a randomized, controlled Study “ERACLES01/2020” | |||||||||||||
Medical condition: Intestinal cleaning in subjects submitted to colonscopy planned between 8:00 and 10.00 a.m.. | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2020-002864-30 | Sponsor Protocol Number: NL73019.018.20 | Start Date*: 2020-07-29 |
Sponsor Name:Amsterdam UMC, location AMC | ||
Full Title: Sulodexide for chronic heart failure: a proof of concept, randomized, placebo-controlled study | ||
Medical condition: Chronic heart failure | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: NL (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2021-002311-64 | Sponsor Protocol Number: SuloPrima | Start Date*: 2021-10-01 | |||||||||||
Sponsor Name:ALFASIGMA CZECH s.r.o. | |||||||||||||
Full Title: Efficacy and safety of sulodexide in the treatment of chronic primary venous disease of the lower extremities: randomized double-blind placebo-controlled clinical trial | |||||||||||||
Medical condition: Chronic primary venous disease of the lower limbs | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: CZ (Prematurely Ended) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2017-002258-36 | Sponsor Protocol Number: RETIPC/01/17 | Start Date*: 2017-11-21 | |||||||||||
Sponsor Name:ALFASIGMA S.P.A. | |||||||||||||
Full Title: A Phase II, multicentre, double-blind, randomised, placebo-controlled study of Rifaximin delayed release 400 mg tablet: clinical efficacy and safety in the prevention of post-operative endoscopic C... | |||||||||||||
Medical condition: Post-operative endoscopic Crohn’s disease recurrence | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Prematurely Ended) BE (Prematurely Ended) ES (Prematurely Ended) NL (Prematurely Ended) IT (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2017-002708-28 | Sponsor Protocol Number: REDIV/002/17 | Start Date*: 2018-02-23 | |||||||||||
Sponsor Name:Alfasigma S.p.a | |||||||||||||
Full Title: Rifaximin delayed release (400 mg tablet) for the prevention of recurrent acute diverticulitis and diverticular complications. A phase II, multicenter, double-blind, placebo-controlled, randomized ... | |||||||||||||
Medical condition: Prevention of recurrent acute diverticulitis and diverticular complications | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Ongoing) DE (Completed) HU (Completed) FR (Completed) NL (Completed) GB (GB - no longer in EU/EEA) PT (Completed) IT (Prematurely Ended) RO (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2021-000854-24 | Sponsor Protocol Number: VE-CIP2001/2021 | Start Date*: 2021-12-21 | |||||||||||
Sponsor Name:ALFASIGMA S.P.A. | |||||||||||||
Full Title: Velusetrag for the treatment of Chronic Intestinal Pseudo-Obstruction (CIPO). A multicenter double-blind, placebo-controlled, cross-over, multiple (n=1) trial. | |||||||||||||
Medical condition: Chronic intestinal pseudo-obstruction (CIPO) is a rare, severe condition characterized by an impairment of coordinated propulsive activity in the intestinal tract resulting in a clinical picture si... | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Ongoing) IT (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2019-002116-10 | Sponsor Protocol Number: i3.1_IBS+SIBO | Start Date*: 2019-09-27 |
Sponsor Name:AB-Biotics S.A. | ||
Full Title: Interventional post-marketing study to evaluate i3.1 efficacy on SIBO (Small Intestinal Bacterial Overgrowth)reduction in IBS (Irritable bowel syndrom) patients | ||
Medical condition: Irritable Bowel Syndrome (IBS) + Small Intestinal Bacterial Overgrowth (SIBO) | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: ES (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2018-001261-16 | Sponsor Protocol Number: Betapred_vid_tonsillektomi | Start Date*: 2018-10-02 |
Sponsor Name:ÖNH-kliniken Sunderby Sjukhus | ||
Full Title: Betamethasone (Betapred®) as premedication for reducing postoperative vomiting and pain after tonsillectomy – a randomized, double-blind, placebo-controlled trial | ||
Medical condition: Postoperative pain, nausea and vomiting following tonsillectomy in patients with chronic or recurrent tonsillitis. | ||
Disease: | ||
Population Age: Adolescents, Under 18, Adults, Elderly | Gender: Male, Female | |
Trial protocol: SE (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2022-002311-39 | Sponsor Protocol Number: 101069207 | Start Date*: 2022-09-07 |
Sponsor Name:University Of Cyprus | ||
Full Title: Phase II trial for the use of ketotifen to enhance therapy in patients with sarcoma receiving standard chemotherapy | ||
Medical condition: Patients with sarcoma | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: CY (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2022-000156-11 | Sponsor Protocol Number: S65914 | Start Date*: 2022-02-25 |
Sponsor Name:KU Leuven | ||
Full Title: Oxytocin and the development of attachment: Looking beyond the expected? | ||
Medical condition: General healthy population children (ages 8 - 13 years old). | ||
Disease: | ||
Population Age: Children, Adolescents, Under 18 | Gender: Male, Female | |
Trial protocol: BE (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2019-004840-30 | Sponsor Protocol Number: PrepDial | Start Date*: 2020-11-04 | |||||||||||
Sponsor Name:Policlinico di Bari-UO Gastroenterologia | |||||||||||||
Full Title: Comparison of low-volume versus high-volume polyethylene glycol based bowel preparation for colonoscopy in people receiving hemodialysis: a randomized non-inferiority trial. | |||||||||||||
Medical condition: Colonoscopy in people receiving hemodialysis | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2018-002877-23 | Sponsor Protocol Number: 1.0 | Start Date*: 2019-01-21 | |||||||||||
Sponsor Name:Abteilung für Neurologie der Medizinischen Universität Innsbruck | |||||||||||||
Full Title: Oxytocin and social attention in healthy controls and patients with Parkinson's disease. A randomised, double-blind, placebo-controlled, crossover eye tracking study. | |||||||||||||
Medical condition: Social functioning in Parkinson's disease | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male | ||||||||||||
Trial protocol: AT (Prematurely Ended) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2010-024202-34 | Sponsor Protocol Number: 24122010 | Start Date*: 2014-04-24 | |||||||||||
Sponsor Name:UNIVERSITÄTSMEDIZIN GÖTTINGEN, GEORG-AUGUST-UNIVERSITÄT,Klinik für Kinder- und Jugendpsychiatrie/Psychotherapie | |||||||||||||
Full Title: Effect of oxytocin on therapy results of a group based social skill training in adolescents with Autism Spectrum Disorder | |||||||||||||
Medical condition: high-functioning autismus spectrum disorders: autistic disorder (F84.0), Asperger syndrome (F84.5), atypical autism (F84.1) | |||||||||||||
|
|||||||||||||
Population Age: Adolescents, Under 18, Adults | Gender: Male | ||||||||||||
Trial protocol: DE (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2022-001958-36 | Sponsor Protocol Number: SDX_01 | Start Date*: 2022-08-29 |
Sponsor Name:Corporativo de Servicios Médicos Especializados S.A de C.V V (Centro Médico del Noroeste) | ||
Full Title: Endothelial protection in convalecent COVID-19 patients. The effect of Sulodexide on serum levels of biomarkers for endothelial dysfunction. A prospective, randomized, placebo-controlled, investiga... | ||
Medical condition: Coronavirus disease 2019 (COVID-19) is an infectious disease caused by coronavirus 2 (SARS-CoV-2) and, thus, being a novel cause of sepsis and the the poor outcome of patients with sepsis was relat... | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: HU (Prematurely Ended) | ||
Trial results: (No results available) |
EudraCT Number: 2019-002280-10 | Sponsor Protocol Number: LBS180319 | Start Date*: 2021-04-14 | |||||||||||
Sponsor Name:St. Olav's University Hospital | |||||||||||||
Full Title: Effects of intranasal oxytocin in the treatment of benzodiazepine withdrawal: A pilot randomized parallel group placebo-controlled trial | |||||||||||||
Medical condition: Benzodiazepine withdrawal and craving | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: NO (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2019-000570-33 | Sponsor Protocol Number: FAAI2.10.2018 | Start Date*: 2019-09-26 | ||||||||||||||||
Sponsor Name:FONDAZIONE ARIANNA ANTICOAGULAZIONE | ||||||||||||||||||
Full Title: The Jason study: Sulodexide (VESSEL®) for the prevention of recurrent venous thromboembolism in elderly patients after a first episode of venous thrombembolism (VTE) | ||||||||||||||||||
Medical condition: Prevention of recurrence after a first episode of VTE | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: IT (Ongoing) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2015-002969-27 | Sponsor Protocol Number: PMF104PD1-2-3/2013 | Start Date*: 2015-12-11 | |||||||||||
Sponsor Name:Alfa Wassermann S.p.A. | |||||||||||||
Full Title: A RANDOMISED, SINGLE-BLIND, ACTIVE CONTROLLED, MULTI-CENTRE TRIAL TO EVALUATE THE EFFICACY, SAFETY, TOLERABILITY, ACCEPTABILITY AND PALATABILITY OF PMF104 COMPARED TO A CONVENTIONAL PEG-ELECTROLYTE... | |||||||||||||
Medical condition: Need of bowel cleansing in order to perform a colonoscopy or any other diagnostic or therapeutic procedure concerning the colon. | |||||||||||||
|
|||||||||||||
Population Age: Children, Adolescents, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Prematurely Ended) BE (Completed) FR (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2019-002799-15 | Sponsor Protocol Number: INTERPRET | Start Date*: 2020-09-16 | |||||||||||
Sponsor Name:ALMA MATER STUDIORUM UNIVERSITà DI BOLOGNA | |||||||||||||
Full Title: Efficacy of a very low-volume Polyethylene Glycole (PEG 1L) bowel preparation vs. low-volume (2L) and high-volume (4L) PEG-based preparations. A randomized controlled study. | |||||||||||||
Medical condition: Adult in hospital patients who undergo colonoscopy for any medical disease | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Ongoing) | |||||||||||||
Trial results: (No results available) |
Subscribe to this Search
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
Query did not match any studies.